Twin Lakes Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $381K | Buy |
15,723
+97
| +0.6% | +$2.35K | 0.23% | 61 |
|
|
2025
Q1 | $396K | Sell |
15,626
-112
| -0.7% | -$2.84K | 0.27% | 59 |
|
|
2024
Q4 | $418K | Sell |
15,738
-4,360
| -22% | -$116K | 0.27% | 56 |
|
|
2024
Q3 | $582K | Buy |
20,098
+143
| +0.7% | +$4.14K | 0.37% | 48 |
|
|
2024
Q2 | $558K | Buy |
19,955
+146
| +0.7% | +$4.09K | 0.38% | 48 |
|
|
2024
Q1 | $550K | Buy |
19,809
+152
| +0.8% | +$4.22K | 0.37% | 50 |
|
|
2023
Q4 | $566K | Buy |
19,657
+130
| +0.7% | +$3.74K | 0.39% | 47 |
|
|
2023
Q3 | $648K | Hold |
19,527
| – | – | 0.48% | 41 |
|
|
2023
Q2 | $716K | Buy |
19,527
+96
| +0.5% | +$3.52K | 0.51% | 41 |
|
|
2023
Q1 | $793K | Buy |
19,431
+91
| +0.5% | +$3.71K | 0.59% | 39 |
|
|
2022
Q4 | $991K | Sell |
19,340
-11
| -0.1% | -$564 | 0.76% | 31 |
|
|
2022
Q3 | $847K | Buy |
19,351
+79
| +0.4% | +$3.46K | 0.68% | 33 |
|
|
2022
Q2 | $1.01M | Sell |
19,272
-93
| -0.5% | -$4.87K | 0.73% | 34 |
|
|
2022
Q1 | $1M | Buy |
19,365
+75
| +0.4% | +$3.89K | 0.57% | 44 |
|
|
2021
Q4 | $1.14M | Buy |
19,290
+78
| +0.4% | +$4.61K | 0.61% | 40 |
|
|
2021
Q3 | $826K | Buy |
19,212
+100
| +0.5% | +$4.3K | 0.48% | 43 |
|
|
2021
Q2 | $748K | Buy |
19,112
+53
| +0.3% | +$2.07K | 0.42% | 43 |
|
|
2021
Q1 | $691K | Buy |
19,059
+735
| +4% | +$26.6K | 0.43% | 44 |
|
|
2020
Q4 | $675K | Buy |
+18,324
| New | +$675K | 0.48% | 43 |
|